Randomised Controlled Trials (RCTs) suggest that it probably does induce less of a rise in intraocular pressure than either dexamethasone sodium 0.1% or prednisolone acetate 1% (the differences did not reach statistical significance [ 8 ]), but it is a weaker corticosteroid that is most useful in controlling chronic anterior uveitis in patients with established glaucoma or who are corticosteroid responders.
← all excerpts
Local therapies for inflammatory eye disease in translation: past, present and future.
1
—
—